Klinefelter Syndrome and Testosterone Treatment in Puberty
Condition(s) studied
Investigational drug(s) / intervention(s)
Testosterone gel: Two years treatment with testosterone
Placebo: Two years treatment with placebo
Study summary
The goal of this randomized clinical trial is to study the effect of testosterone replacement therapy during puberty in boys with Klinefelter syndrome (KS, 47,XXY).
The main questions to answer are how treatment with testosterone will affect body fat mass, lipid and glucose metabolism, growth and body proportions, bone mineralization as well as effects on neurocognitive development and emotional and social difficulties.
Participants will be randomized to two years treatment with testosterone or placebo.
Eligibility
Primary outcome measure(s)
- Changes in body fat mass — Baseline and 1 and two years
Evaluation of body fat percentage by whole body dual energy x-ray absorptiometry (DEXA) scan
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Copenhagen University Hospital, Rigshospitalet | Copenhagen | Denmark | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06294990 on ClinicalTrials.gov ↗ ← All trials in Denmark